The Novel Unloading Device "HEPHAISTOS" and Its Effects Upon Bone, Muscle and Vasculature
NCT ID: NCT01576081
Last Updated: 2012-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2011-04-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Primary objective: Assessment and evaluation of bone adaptation.
2. Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.
3. Third objective: Assessment and evaluation of functional and structural vascular adaptations.
4. Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unilateral orthotic intervention
The HEPHAISTOS orthotic was worn unilaterally for 56days by 11 healthy male subjects.
HEPHAISTOS
HEPHAISTOS unloading orthotic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEPHAISTOS
HEPHAISTOS unloading orthotic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age: 20-40 years
* BMI: 20-30
* passing the psychological and medical check up.
* signed consent to participate in the study
* faultless certificate of good conduct
Exclusion Criteria
* professional athletes
* diabetes
* muscle or joint disease
* trabecular bone density in the distal tibia epiphysis \< 160mg/cm3
* increase risk of thrombosis
* bone fractures 12 months prior to the study
* metal implants, any material of osteosynthesis
* participation in another clinical intervention study 2 months prior to the study
* bleeding disorder
* anesthetic intolerance
* vascular disease
* epilepsy
* claustrophobia
* herniated disk
* pacemaker
* alcohol or drug abuse
* anti-inflammatory drug intake during the study
* hyperlipidemia
* kidney disease
* hyperhomocysteinaemia
* vitamin d deficit
* chronical back pain
* detained
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DLR German Aerospace Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joern Rittweger, Prof. Dr.
Role: STUDY_DIRECTOR
DLR German Aerospace Center
Tobias Weber
Role: PRINCIPAL_INVESTIGATOR
DLR German Aerospace Center
Michel Ducos
Role: PRINCIPAL_INVESTIGATOR
DLR German Aerospace Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Aerospace Center
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weber T, Ducos M, Mulder E, Beijer A, Herrera F, Zange J, Degens H, Bloch W, Rittweger J. The relationship between exercise-induced muscle fatigue, arterial blood flow and muscle perfusion after 56 days local muscle unloading. Clin Physiol Funct Imaging. 2014 May;34(3):218-29. doi: 10.1111/cpf.12087. Epub 2013 Oct 7.
Weber T, Ducos M, Mulder E, Herrera F, Bruggemann GP, Bloch W, Rittweger J. The specific role of gravitational accelerations for arterial adaptations. J Appl Physiol (1985). 2013 Feb;114(3):387-93. doi: 10.1152/japplphysiol.01117.2012. Epub 2012 Dec 6.
Related Links
Access external resources that provide additional context or updates about the study.
Webpage German Aerospace Center (DLR), Division Space Physiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DLR
Identifier Type: -
Identifier Source: org_study_id